TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation
Brief Summary: The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.


Options:
A: Arm Label: ACT Group 1; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance and Commitment Therapy, Drug: Varenicline | Arm Label: MBC Group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational and Behavioral Counseling, Drug: Varenicline | Intervention Type: BEHAVIORAL; Name: Acceptance and Commitment Therapy; Assigned to Arm(s): ACT Group 1 | Intervention Type: BEHAVIORAL; Name: Motivational and Behavioral Counseling; Assigned to Arm(s): MBC Group 2 | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): ACT Group 1, MBC Group 2
B: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Intervention Type: BEHAVIORAL; Name: ACT; Assigned to Arm(s): ACT | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
C: Arm Label: Mindfulness in nature; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness | Arm Label: Mindfulness indoor; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness | Arm Label: Wait list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness; Assigned to Arm(s): Mindfulness in nature, Mindfulness indoor
D: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone-delivered Intervention (SmartQuit) | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: : Smartphone-delivered Intervention (Standard of care app) | Intervention Type: BEHAVIORAL; Name: Smartphone-delivered Intervention (SmartQuit); Assigned to Arm(s): Experimental | Intervention Type: BEHAVIORAL; Name: : Smartphone-delivered Intervention (Standard of care app); Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation
Brief Summary: The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.


Options:
A: Arm Label: Participants; Type: N/A; Interventions: N/A
B: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Intervention Type: BEHAVIORAL; Name: ACT; Assigned to Arm(s): ACT | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone-delivered Intervention (SmartQuit) | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: : Smartphone-delivered Intervention (Standard of care app) | Intervention Type: BEHAVIORAL; Name: Smartphone-delivered Intervention (SmartQuit); Assigned to Arm(s): Experimental | Intervention Type: BEHAVIORAL; Name: : Smartphone-delivered Intervention (Standard of care app); Assigned to Arm(s): Control
D: Arm Label: Mindfulness-based Addiction Treatment (MBAT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness-based Addiction Treatment, Behavioral: Self-Help guide, Drug: Nicotine Patch | Arm Label: iQuit Mindfully; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based Addiction Treatment, Behavioral: iQuit Mindfully, Behavioral: Self-Help guide, Drug: Nicotine Patch | Intervention Type: BEHAVIORAL; Name: Mindfulness-based Addiction Treatment; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully | Intervention Type: BEHAVIORAL; Name: iQuit Mindfully; Assigned to Arm(s): iQuit Mindfully | Intervention Type: BEHAVIORAL; Name: Self-Help guide; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Mindfulness-based Addiction Treatment (MBAT), iQuit Mindfully

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%
Brief Summary: Our study will investigate inhalation therapy of NaCl 3% compared to standard therapy with no inhalation in the treatment of moderate to severe bronchiolitis. The impact on length of hospital stay will be analyzed.


Options:
A: Arm Label: Nebulized Hypertonic Saline; Type: EXPERIMENTAL; Interventions: Drug: 3% sodium chloride | Arm Label: Nebulized Normal Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% sodium chloride | Intervention Type: DRUG; Name: 3% sodium chloride; Assigned to Arm(s): Nebulized Hypertonic Saline | Intervention Type: DRUG; Name: 0.9% sodium chloride; Assigned to Arm(s): Nebulized Normal Saline
B: Arm Label: NaCl 3% inhalations + standard therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: NaCl 3%, Other: Standard therapy | Arm Label: Standard therapy; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard therapy | Intervention Type: DRUG; Name: NaCl 3%; Assigned to Arm(s): NaCl 3% inhalations + standard therapy | Intervention Type: OTHER; Name: Standard therapy; Assigned to Arm(s): NaCl 3% inhalations + standard therapy, Standard therapy
C: Arm Label: Hypertonic; Type: EXPERIMENTAL; Interventions: Drug: Hypertonic saline | Arm Label: Normal; Type: ACTIVE_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Hypertonic saline; Assigned to Arm(s): Hypertonic | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Normal
D: Arm Label: hypertonic saline and usual care; Type: ACTIVE_COMPARATOR; Interventions: Device: 3% hypertonic saline | Arm Label: usual care (oxygen therapy); Type: ACTIVE_COMPARATOR; Interventions: Device: 3% hypertonic saline | Intervention Type: DEVICE; Name: 3% hypertonic saline; Assigned to Arm(s): hypertonic saline and usual care, usual care (oxygen therapy)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization
Brief Summary: This study will evaluate whether low-density lipoprotein (LDL-C) lowering with evolocumab (AMG 145) results in greater change from baseline in percent atheroma volume (PAV) at week 78 than placebo in adults with coronary artery disease taking lipid lowering therapy.


Options:
A: Arm Label: Alirocumab therapy group; Type: EXPERIMENTAL; Interventions: Drug: Alirocumab | Arm Label: standard statin therapy group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Alirocumab; Assigned to Arm(s): Alirocumab therapy group
B: Arm Label: Bococizumab (PF-04950615; RN316); Type: EXPERIMENTAL; Interventions: Drug: Bococizumab (PF-04950615; RN316) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Bococizumab (PF-04950615; RN316); Assigned to Arm(s): Bococizumab (PF-04950615; RN316) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Evolocumab; Type: EXPERIMENTAL; Interventions: Biological: Evolocumab | Intervention Type: BIOLOGICAL; Name: Evolocumab; Assigned to Arm(s): Evolocumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo Q2W; Type: PLACEBO_COMPARATOR; Interventions: Drug: Alirocumab, Drug: Placebo (for Alirocumab), Drug: Non-statin LMT, Other: Diet Alone | Arm Label: Alirocumab 75 mg Q2W/Up to 150 mg Q2W (Calibrator); Type: OTHER; Interventions: Drug: Alirocumab, Drug: Non-statin LMT, Other: Diet Alone | Arm Label: Alirocumab 150 mg Q4W/Up to 150 mg Q2W; Type: EXPERIMENTAL; Interventions: Drug: Alirocumab, Drug: Placebo (for Alirocumab), Drug: Non-statin LMT, Other: Diet Alone | Intervention Type: DRUG; Name: Alirocumab; Assigned to Arm(s): Alirocumab 150 mg Q4W/Up to 150 mg Q2W, Alirocumab 75 mg Q2W/Up to 150 mg Q2W (Calibrator), Placebo Q2W | Intervention Type: DRUG; Name: Placebo (for Alirocumab); Assigned to Arm(s): Alirocumab 150 mg Q4W/Up to 150 mg Q2W, Placebo Q2W | Intervention Type: DRUG; Name: Non-statin LMT; Assigned to Arm(s): Alirocumab 150 mg Q4W/Up to 150 mg Q2W, Alirocumab 75 mg Q2W/Up to 150 mg Q2W (Calibrator), Placebo Q2W | Intervention Type: OTHER; Name: Diet Alone; Assigned to Arm(s): Alirocumab 150 mg Q4W/Up to 150 mg Q2W, Alirocumab 75 mg Q2W/Up to 150 mg Q2W (Calibrator), Placebo Q2W

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
Brief Summary: After a stent procedure, it is common practice to prescribe anti-platelet medication to prevent the blood from clotting. The main objective of this study is to determine if there is a better medication strategy to prevent blood from clotting and at the same time minimising the number of complications.

There are two medication strategies:

* Study group: Dual anti-platelet therapy (ticagrelor combined with aspirin) for 1 month, and then ticagrelor alone for another 23 months OR
* Control group: Standard treatment, being dual anti-platelet therapy (ticagrelor or clopidogrel combined with aspirin) for 12 months, and then aspirin alone indefinitely


Options:
A: Arm Label: Eptifibatide; Type: EXPERIMENTAL; Interventions: Drug: Eptifibatide (Integrilin) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Eptifibatide (Integrilin); Assigned to Arm(s): Eptifibatide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Combination Clopidogrel and asprin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel | Arm Label: Asprin and placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of clopidogrel and Asprin | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Combination Clopidogrel and asprin | Intervention Type: DRUG; Name: Placebo of clopidogrel and Asprin; Assigned to Arm(s): Asprin and placebo
C: Arm Label: Prasugrel; Type: EXPERIMENTAL; Interventions: Drug: Prasugrel | Arm Label: Clopidogrel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel | Intervention Type: DRUG; Name: Prasugrel; Assigned to Arm(s): Prasugrel | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Clopidogrel
D: Arm Label: Experimental treatment strategy; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor, Drug: Acetylsalicylic Acid | Arm Label: Reference treatment strategy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ticagrelor, Drug: Acetylsalicylic Acid, Drug: Clopidogrel | Intervention Type: DRUG; Name: Ticagrelor; Assigned to Arm(s): Experimental treatment strategy, Reference treatment strategy | Intervention Type: DRUG; Name: Acetylsalicylic Acid; Assigned to Arm(s): Experimental treatment strategy, Reference treatment strategy | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Reference treatment strategy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of an Elemental Formula in Infants With Protein Sensitive Colitis
Brief Summary: Infants with protein sensitive colitis fed a nutritionally complete free amino acid-based medical food will be evaluated for 42 days.


Options:
A: Arm Label: parenteral nutrition solution; Type: OTHER; Interventions: Drug: Ped3CB | Intervention Type: DRUG; Name: Ped3CB; Assigned to Arm(s): parenteral nutrition solution
B: Arm Label: Control Study Formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Control Study Formula | Arm Label: Experimental Study Formula; Type: EXPERIMENTAL; Interventions: Other: Experimental Study Formula | Intervention Type: OTHER; Name: Control Study Formula; Assigned to Arm(s): Control Study Formula | Intervention Type: OTHER; Name: Experimental Study Formula; Assigned to Arm(s): Experimental Study Formula
C: Arm Label: Experimental Infant Formula; Type: EXPERIMENTAL; Interventions: Other: Experimental Infant Formula | Intervention Type: OTHER; Name: Experimental Infant Formula; Assigned to Arm(s): Experimental Infant Formula
D: Arm Label: Isoleucine; Type: ACTIVE_COMPARATOR; Interventions: Other: ORS + Isoleucine | Arm Label: ORS without Isoleucine; Type: PLACEBO_COMPARATOR; Interventions: Other: ORS without Isoleucine | Intervention Type: OTHER; Name: ORS + Isoleucine; Assigned to Arm(s): Isoleucine | Intervention Type: OTHER; Name: ORS without Isoleucine; Assigned to Arm(s): ORS without Isoleucine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients ("ACTINUT" Study), Multicenter, Randomized, Controlled Open Label Trial Study Multicenter, Prospective, Randomized Study
Brief Summary: Sedentary behavior and protein-energy wasting (PEW) are well known risk factors of adverse outcome and low quality of life in chronic renal failure patients treated by dialysis. Treatment strategies of PEW by different types of nutritional support (as dietary counseling, oral nutritional supplements or intradialytic parenteral nutrition) have limited efficacy. Physical activity has been shown to have numerous positive impacts in pathologic conditions associated to end stage renal disease.

Concomitant prescription of physical activity and nutritional support might mutually enhance the anabolic effects of these interventions and improve the rate of remission of PEW.

The aim of this study is to analyze the effect of a programmed, progressive endurance training performed during the dialysis session on a cycle ergometer under the supervision of a qualified trainer, on protein energy wasting and physical functioning of chronic hemodialysis patients.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Pro-Stat | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Pro-Stat | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Pro-Stat; Assigned to Arm(s): 1, 2
B: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: activity group; Type: EXPERIMENTAL; Interventions: Device: Exercise training in addition to nutritional support | Intervention Type: DEVICE; Name: Exercise training in addition to nutritional support; Assigned to Arm(s): activity group
C: Arm Label: whey drink; Type: EXPERIMENTAL; Interventions: Dietary Supplement: whey drink, | Arm Label: whey drink fortified with vitaminE; Type: EXPERIMENTAL; Interventions: Dietary Supplement: whey drink fortified with vitaminE | Arm Label: vitaminE; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin E | Arm Label: D- control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: whey drink,; Assigned to Arm(s): whey drink | Intervention Type: DIETARY_SUPPLEMENT; Name: whey drink fortified with vitaminE; Assigned to Arm(s): whey drink fortified with vitaminE | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin E; Assigned to Arm(s): vitaminE
D: Arm Label: Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of Care | Arm Label: Nepro with Carb Steady; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nepro with Carb Steady | Intervention Type: DIETARY_SUPPLEMENT; Name: Nepro with Carb Steady; Assigned to Arm(s): Nepro with Carb Steady | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Standard of Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients ("ACTINUT" Study), Multicenter, Randomized, Controlled Open Label Trial Study Multicenter, Prospective, Randomized Study
Brief Summary: Sedentary behavior and protein-energy wasting (PEW) are well known risk factors of adverse outcome and low quality of life in chronic renal failure patients treated by dialysis. Treatment strategies of PEW by different types of nutritional support (as dietary counseling, oral nutritional supplements or intradialytic parenteral nutrition) have limited efficacy. Physical activity has been shown to have numerous positive impacts in pathologic conditions associated to end stage renal disease.

Concomitant prescription of physical activity and nutritional support might mutually enhance the anabolic effects of these interventions and improve the rate of remission of PEW.

The aim of this study is to analyze the effect of a programmed, progressive endurance training performed during the dialysis session on a cycle ergometer under the supervision of a qualified trainer, on protein energy wasting and physical functioning of chronic hemodialysis patients.


Options:
A: Arm Label: Functional training and cycling; Type: EXPERIMENTAL; Interventions: Other: Functional training and cycling | Arm Label: Cycling; Type: ACTIVE_COMPARATOR; Interventions: Other: Cycling | Intervention Type: OTHER; Name: Functional training and cycling; Assigned to Arm(s): Functional training and cycling | Intervention Type: OTHER; Name: Cycling; Assigned to Arm(s): Cycling
B: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: activity group; Type: EXPERIMENTAL; Interventions: Device: Exercise training in addition to nutritional support | Intervention Type: DEVICE; Name: Exercise training in addition to nutritional support; Assigned to Arm(s): activity group
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise
D: Arm Label: HD-Exercise-HDF; Type: EXPERIMENTAL; Interventions: Procedure: Intra-dialytic exercise | Intervention Type: PROCEDURE; Name: Intra-dialytic exercise; Assigned to Arm(s): HD-Exercise-HDF

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Business of Childcare Homes & Child Health: Innovations for Nurturing Growth
Brief Summary: The purpose of this project is to evaluate the efficacy of a 9-month Family Child Care Home (FCCH)-based intervention, Keys to Healthy Family Child Care Homes, to increase the physical activity and improve the diet quality of children (1.5 to 4.9 years).


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Parents Connect for Healthy Living (PConnect), Behavioral: Enhanced Nutrition Support, Behavioral: Media Resources | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parents Connect for Healthy Living (PConnect); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Nutrition Support; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Media Resources; Assigned to Arm(s): Intervention
B: Arm Label: Healthy Lifestyles Group; Type: EXPERIMENTAL; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Arm Label: Healthy Business Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Intervention Type: BEHAVIORAL; Name: Keys to Healthy Family Child Care Homes; Assigned to Arm(s): Healthy Business Group, Healthy Lifestyles Group
C: Arm Label: Center-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Center-based Intervention | Arm Label: Center-and-home-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based Intervention | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Control | Intervention Type: BEHAVIORAL; Name: Center-based Intervention; Assigned to Arm(s): Center-based intervention | Intervention Type: BEHAVIORAL; Name: Home-based Intervention; Assigned to Arm(s): Center-and-home-based intervention | Intervention Type: BEHAVIORAL; Name: Active Control; Assigned to Arm(s): Active Control
D: Arm Label: Train-the-Trainers Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Caregivers- Healthy Children Toolkit | Arm Label: Attention Control Arm; Type: OTHER; Interventions: Behavioral: Safety Curriculum | Intervention Type: BEHAVIORAL; Name: Healthy Caregivers- Healthy Children Toolkit; Assigned to Arm(s): Train-the-Trainers Arm | Intervention Type: BEHAVIORAL; Name: Safety Curriculum; Assigned to Arm(s): Attention Control Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Business of Childcare Homes & Child Health: Innovations for Nurturing Growth
Brief Summary: The purpose of this project is to evaluate the efficacy of a 9-month Family Child Care Home (FCCH)-based intervention, Keys to Healthy Family Child Care Homes, to increase the physical activity and improve the diet quality of children (1.5 to 4.9 years).


Options:
A: Arm Label: Healthy Lifestyles Group; Type: EXPERIMENTAL; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Arm Label: Healthy Business Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Intervention Type: BEHAVIORAL; Name: Keys to Healthy Family Child Care Homes; Assigned to Arm(s): Healthy Business Group, Healthy Lifestyles Group
B: Arm Label: 1M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 1M1.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 3M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Timing of Diet and Flavor Experience; Assigned to Arm(s): 1M0.5, 1M1.5, 3M0.5
C: Arm Label: Hummus and vegetables; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables, Other: Hummus | Arm Label: Vegetables only; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables | Intervention Type: OTHER; Name: Lesson about vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Hummus; Assigned to Arm(s): Hummus and vegetables
D: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons

Answer: A